Template:Cefuroxime axetil: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil how supplied|How Supplied]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil how supplied|How Supplied]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime clinical studies |Clinical Studies ]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil clinical studies |Clinical Studies ]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil labels and packages|Labels and Packages]] | ||
|- | |- | ||
|} | |} | ||